| ●Editorial | Kurihara C | 4-7 | Full text | ||||
| ●Cornerstone of next generation research and development: Overcoming COVID-19 pandemic | |||||||
| ・Articles | |||||||
| Promotion of the Utilization of Real-World Data under the Revised Next Generation Medical Infrastructure Act | Yshihara H，Anan K | 9-22 | Abstract | ||||
| The role of telemedicine in end-of-life care for the elderly | Sakai M，Uchida T | 23-7 | Full text | ||||
| Results of a career survey of physicians and PhD researchers with 10 years or longer tenure in the pharmaceutical industry | Tamada H，Maeda-Chubachi T， Mukai H，et al． | 29-42 | Abstract | ||||
| Points to note when interpreting on Excess Deaths presented by the National Institute of Infectious Diseases in Japan | Suzumura Y | 43-58 | Full text | ||||
| Editor’s note to Suzumura’s article “Points to note when interpreting on Excess Deaths presented by the National Institute of Infectious Diseases in Japan” | Kurihara C | 59-61 | Full text | ||||
| ・Translation and explanatory article | |||||||
| Unveiling Excess Mortality: How to know the fact as it is | Fukushima M | 63-4 | Full text | ||||
| Increased age-adjusted cancer mortality after the third mRNA-lipid nanoparticle vaccine dose during the COVID-19 pandemic in Japan | Gibo M，Kojima S，Fujisawa A，et al． （Translated and supervised by Gibo M Supervised by Kojima S，Fujisawa A， Kikuchi T，Fukushima M Translated by Hirai Y） |
65-90 | Full text | ||||
| ●For the 2024 revision of the Declaration of Helsinki: From the “Ethical innovation for global health” | |||||||
| Our “WMA Declaration of Helsinki” －Opinions and proposals from patient and public－ | Kurihara C，Inoue K，Kai H，et al． | 91-131 | Full text | ||||
| Ethics of placebo-controlled trials: Historical analysis including experiences during the COVID-19 pandemic | Kurihara C，Greco D，Dhai A，et al． （Trans. by Kurihara C，Saio T） | 133-59 | Full text | ||||
| Post-trial access: Historical analysis considering the experience of COVID-19 pandemic | Kurihara C，Greco D，Dhai A （Trans. by Kurihara C） | 161-77 | Full text | ||||
| ●Instructions for authors［Japanese］＆［English］ | 179-87 | Full text | |||||
| ●Editor’s note | Imamura K | 189 | Full text | ||||